Stay updated on Pembrolizumab in Glioblastoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Glioblastoma Clinical Trial page.

Latest updates to the Pembrolizumab in Glioblastoma Clinical Trial page
- Check3 days agoChange DetectedThe page now displays a new Revision: v3.6.2 label, replacing the previous Revision: v3.6.0, indicating a newer page version.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check18 days agoChange DetectedRecruitment status now indicates that no participants are being sought. New help/navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study), and the treatment header formatting was updated along with a revision tag increment from v3.5.5 to v3.6.0.SummaryDifference0.5%

- Check25 days agoChange DetectedThe page revision updated from v3.5.4 to v3.5.5. This represents a small software release and does not change study data or how information is displayed.SummaryDifference0.1%

- Check46 days agoChange DetectedThe page’s revision tag was updated from v3.5.3 to v3.5.4 to indicate deployed template updates; no substantive content changes are reflected in this change.SummaryDifference0.1%

- Check53 days agoChange DetectedRevision label updated from v3.5.2 to v3.5.3, indicating a newer version of the page metadata. There are no visible changes to the study details or user-facing content.SummaryDifference0.1%

- Check75 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Glioblastoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Glioblastoma Clinical Trial page.